宝莱特前三季度再现亏损，毛利率持续下滑

Core Insights - Baolait's Q3 2023 performance shows a decline in revenue and net profit, with a total revenue of 7.93 billion yuan for the first three quarters, down 1.77% year-on-year, and a net loss of 8.34 million yuan, although the loss has narrowed compared to previous periods [1][2] Financial Performance - In Q3 2023, the company's revenue was 2.7 billion yuan, a decrease of 0.5% year-on-year, with a net loss of 9.66 million yuan, improving from a loss of 11.13 million yuan in the same period last year [1] - For the first three quarters, the gross profit margin fell from 27.18% to 25.31%, with projected gross profit margins of 32.43% and 27.12% for 2023 and 2024 respectively, indicating a continuous decline [1] Company Overview - Baolait specializes in the research, production, and sales of medical monitoring devices, primarily multi-parameter monitors, including handheld monitors, integrated monitors, and plug-in monitors [2] - The company's revenue from 2021 to 2024 shows a downward trend, with figures of 10.91 billion yuan, 11.84 billion yuan, 11.94 billion yuan, and 10.60 billion yuan, reflecting a significant revenue pressure [2] Debt and Guarantees - As of the announcement date, the company has provided guarantees totaling 400 million yuan for its subsidiaries, which represents 32.82% of the latest audited net assets and 16.01% of the latest audited total assets [2]